29.09
-0.24
(-0.82%)
2.9M
XNAS Volume
XNAS 20 Jun, 2025 4:01 PM (EDT)
Analyst Upgrade
UBS upgrades Alkermes to 'Buy'; cites confidence in the company’s orexin receptor drug
See details
